US Patent 8309532 Therapeutic uses of inhibitors of RTP801
Patent 8309532 was granted and assigned to Quark Pharmaceuticals Inc on November, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8309532 Therapeutic uses of inhibitors of RTP801
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
